These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24453714)

  • 21. Physical activity as a correlate of symptoms, quality of life, comorbidity, and disability status in Hispanics with multiple sclerosis.
    Silveira SL; Motl RW; Marquez DX; Lancia S; Salter A
    Disabil Health J; 2023 Apr; 16(2):101398. PubMed ID: 36402726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of fatigue with disability and accelerometer-measured daily physical activity in patients with relapsing-remitting MS.
    Luostarinen M; Remes AM; Urpilainen P; Takala S; Venojärvi M
    Mult Scler Relat Disord; 2023 Oct; 78():104908. PubMed ID: 37517311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite.
    Costelloe L; O'Rourke K; McGuigan C; Walsh C; Tubridy N; Hutchinson M
    Mult Scler; 2008 Mar; 14(2):255-8. PubMed ID: 17942522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.
    Meador W; Salter AR; Rinker JR
    Int J MS Care; 2016; 18(3):147-53. PubMed ID: 27252602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
    Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
    JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
    de David AC; Sasaki JE; Ramari C; Tauil CB; Moraes AG; Martins F; von Glehn F; Motl RW
    Mult Scler Relat Disord; 2019 May; 30():208-214. PubMed ID: 30818129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MS functional composite: relation to disease phenotype and disability strata.
    Kalkers NF; de Groot V; Lazeron RH; Killestein J; Adèr HJ; Barkhof F; Lankhorst GJ; Polman CH
    Neurology; 2000 Mar; 54(6):1233-9. PubMed ID: 10746590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group.
    Schwartz CE; Vollmer T; Lee H
    Neurology; 1999 Jan; 52(1):63-70. PubMed ID: 9921850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].
    Kotterba S; Eren E; Fangerau T; Malin JP; Sindern E
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):590-4. PubMed ID: 14608510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons of patient self-report, neurologic examination, and functional impairment in MS.
    Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH
    Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.
    Meyer-Moock S; Feng YS; Maeurer M; Dippel FW; Kohlmann T
    BMC Neurol; 2014 Mar; 14():58. PubMed ID: 24666846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
    Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ
    Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
    Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
    Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker.
    Kalkers NF; Bergers L; de Groot V; Lazeron RH; van Walderveen MA; Uitdehaag BM; Polman CH; Barkhof F
    Neurology; 2001 Jan; 56(2):215-9. PubMed ID: 11160958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
    Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-cultural adaptation, validity and reliability of the Turkish version of the patient determined disease steps scale in persons with multiple sclerosis.
    Kahraman T; Özdoğar AT; Özakbaş S
    Physiother Theory Pract; 2021 Apr; 37(4):527-534. PubMed ID: 31218917
    [No Abstract]   [Full Text] [Related]  

  • 39. Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.
    Theodorsdottir A; Nielsen HH; Ravnborg MH; Illes Z
    Mult Scler Relat Disord; 2023 Mar; 71():104550. PubMed ID: 36842312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
    Hadjimichael O; Vollmer T; Oleen-Burkey M;
    Health Qual Life Outcomes; 2008 Nov; 6():100. PubMed ID: 19014588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.